[e-farmacos] Cox2, efectos CVS y otros aines en el BMJ

["Canas, Martin" <macanas@netverk.com.ar>]

Estimadas y estimados,

Dos estudios observacionales con cox2 y variables cardiovasculares, y un
editorial  para ponerle perspectiva y llamar a ua interpretacion precavida
de los resultados.

Saludos,

Martin

Marie Hudson, Hugues Richard, Louise Pilote. Differences in outcomes of
patients with congestive heart failure prescribed celecoxib, rofecoxib, or
non-steroidal anti-inflammatory drugs: population based study:
http://bmj.com/cgi/content/full/330/7504/1370?etoc

Julia Hippisley-Cox, Carol Coupland . Risk of myocardial infarction in
patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal
anti-inflammatory drugs: population based nested case-control analysis:
http://bmj.com/cgi/content/full/330/7504/1366?etoc

El editorial:
Peter Juni, Stephan Reichenbach, Matthias Egger. COX 2 inhibitors,
traditional NSAIDs, and the heart
http://bmj.com/cgi/content/full/330/7504/1342?etoc


Martin Canas
GAPURMED
La Plata
(Argentina)
macanas@netverk.com.ar